GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $8.3M

Liabilities Breakdown FY2021

Total Liabilities: $2.5M